Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

Medical Journal of Australia

Volumn 175, Issue 9, 2001, Pages 480-483

  Ward, P W ^a   Johnson, P D R ^a   Grabsch, E A ^a   Mayall, B C ^a   Grayson, M L ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; MEROPENEM; METRONIDAZOLE; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PSEUDOMONIC ACID; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL INFECTION; BACTERIUM ISOLATE; BELOW KNEE AMPUTATION; CASE REPORT; DISEASE TRANSMISSION; DRUG BLOOD LEVEL; ENTEROBACTER; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; GANGRENE; HEPATITIS C; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PERIPHERAL VASCULAR DISEASE; RASH; RISK FACTOR; TREATMENT FAILURE;

EID: 0035813270     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143681.x     Document Type: Article

References (24)

1. Vancomycin
2. Vancomycin, teicoplanin, and the streptogramins: Quinupristin and dalfopristin
3. Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years
4. The independent evolution of resistance to ciprofloxacin, rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group of Antimicrobial Resistance (AGAR)
5. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
6. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
7. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
8. Heterogeneous resistance to vancomycin in Staphylococcus aureus
9. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand
10. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance
11. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides
12. Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know
13. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
14. Staphylococcus aureus with reduced susceptibility to vancomycin- Illinois, 1999
15. Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area
16. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
17. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
18. Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus
19. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
20. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
21. Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci
22. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
23. Linezolid resistance in a clinical isolate of Staphylococcus aureus